PHGE BIOMX INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOMX INC reported revenue of $332K, net income of −$3.85M and diluted EPS of $0.37; for the fiscal year ended December 2025 revenue was n/a.
PHGE annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$41.5M, net income −$36.2M (margin n/a), EPS $22.19
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$44.5M, net income −$17.7M (margin n/a), EPS $58.31
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$25.3M, net income −$26.2M (margin n/a), EPS $5.10
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$27.2M, net income −$28.3M (margin n/a), EPS $0.95
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$35.5M, net income −$36.2M (margin n/a), EPS $1.39
PHGE quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $332K, net income −$3.85M, EPS $0.37
- Quarter ended Mar 31, 2026: revenue n/a, net income −$19.1M, EPS $7.38
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$13.3M, EPS $11.97
- Quarter ended Sep 30, 2025: revenue n/a, net income −$9.17M, EPS $0.29
- Quarter ended Jun 30, 2025: revenue n/a, net income −$6.04M, EPS $3.66
- Quarter ended Mar 31, 2025: revenue n/a, net income −$7.66M, EPS $6.27
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$14.5M, EPS $55.15
- Quarter ended Sep 30, 2024: revenue n/a, net income $9.64M, EPS −$0.31
- Quarter ended Jun 30, 2024: revenue n/a, net income $4.47M, EPS $0.69
- Quarter ended Mar 31, 2024: revenue n/a, net income −$17.3M, EPS $2.78
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$5.49M, EPS $3.48
- Quarter ended Sep 30, 2023: revenue n/a, net income −$7.91M, EPS $1.30
- Quarter ended Jun 30, 2023: revenue n/a, net income −$6.41M, EPS $0.12
- Quarter ended Mar 31, 2023: revenue n/a, net income −$6.36M, EPS $0.20
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$5.89M, EPS $0.20
- Quarter ended Sep 30, 2022: revenue n/a, net income −$6.78M, EPS $0.23
- Quarter ended Jun 30, 2022: revenue n/a, net income −$7.48M, EPS $0.25
- Quarter ended Mar 31, 2022: revenue n/a, net income −$8.17M, EPS $0.27
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$10.5M, EPS $0.37
- Quarter ended Sep 30, 2021: revenue n/a, net income −$10.0M, EPS $0.37
PHGE cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$26.4M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$37.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$21.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$29.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$27.6M, share buybacks n/a
PHGE balance sheet
- Jun 30, 2026: cash $347K, total assets $28.2M, total liabilities $10.6M, shareholders' equity $10.9M, long-term debt $247K
- Mar 31, 2026: cash $1.17M, total assets $3.25M, total liabilities $4.13M, shareholders' equity −$881K
- Dec 31, 2025: cash $4.36M, total assets $5.78M, total liabilities $7.09M, shareholders' equity −$1.30M
- Sep 30, 2025: cash $6.92M, total assets $26.2M, total liabilities n/a, shareholders' equity $10.5M
- Jun 30, 2025: cash $14.0M, total assets $38.1M, total liabilities n/a, shareholders' equity $19.2M
- Mar 31, 2025: cash $20.1M, total assets $45.7M, total liabilities n/a, shareholders' equity $24.5M
- Dec 31, 2024: cash $16.9M, total assets $43.2M, total liabilities n/a, shareholders' equity $24.1M
- Sep 30, 2024: cash $23.5M, total assets $60.0M, total liabilities n/a, shareholders' equity $37.9M
Is PHGE profitable?
No. BIOMX INC lost $45.5M over the last four quarters.
What is PHGE's EPS?
Diluted earnings per share over the last four quarters were $20.01; $0.37 in the latest quarter.